Drug Type Small molecule drug |
Synonyms NDC 1308, NDC-1308, NDC-1308 (MC1) + [1] |
Target |
Mechanism ERβ agonists(Estrogen receptor beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H38O3 |
InChIKeyWIJIRYKVMWGBHO-NXYDILSSSA-N |
CAS Registry1227511-09-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | - | |
COVID-19 | Preclinical | US | - | |
Diabetes Mellitus, Type 2 | Preclinical | US | - | |
Multiple Sclerosis | Preclinical | US | - | |
Neuromyelitis Optica | Preclinical | US | - | |
Niemann-Pick Disease, Type C | Preclinical | US | - |